Literature DB >> 1415305

Implementation of capillary blood glucose monitoring in a teaching hospital and determination of program requirements to maintain quality testing.

K Lewandrowski1, R Cheek, D M Nathan, J E Godine, K Hurxthal, K Eschenbach, M Laposata.   

Abstract

PURPOSE: To study the implementation of bedside capillary glucose monitoring using a hospital-wide quality control (QC) program.
METHODS: A prospective study of QC performance in 7 outpatient and 39 inpatient treatment units was performed in a large teaching hospital over a 2-year period. Approximately 800 nurses were trained to perform bedside capillary glucose monitoring (Accu-Chek II, Boehringer-Mannheim, Indianapolis, IN). An eight-point QC program was instituted including proficiency testing, instrument maintenance, performance of daily controls, storage of reagent strips and supplies, instrument calibration, and documentation procedures.
RESULTS: Comparison of laboratory and bedside test results (split-sample proficiency testing) revealed Y = 1.004X + 7.26, r = 0.95, with a mean percent difference of -4.2% (p < 0.001). Less than 7% of results fell outside +/- 20% of the laboratory results. QC scores (0 = worst to 4 = best), based on adherence to the QC program, improved from 0 on the first inspection to 3.7 +/- 0.17 by the 11th inspection. The most common QC deficiencies were failure to perform split-sample testing (41.4%) and failure to perform instrument maintenance (30.2%). Significant differences were noted in the QC performance of different types of medical services. During the 2-year study period, the total number of glucose assays performed in the clinical laboratories decreased by 22.2% concurrent with initiation of bedside testing. The number of instruments in the hospital increased from 10 to 46.
CONCLUSIONS: Bedside capillary glucose assays can be widely implemented in large hospitals with an acceptable degree of accuracy. QC programs with frequent inspections are necessary to identify units that function inadequately, and a formal disciplinary policy is required to ensure compliance with the program.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415305     DOI: 10.1016/0002-9343(92)90172-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  2 in total

1.  Performance of the CONTOUR® TS Blood Glucose Monitoring System.

Authors:  Joy Frank; Jane F Wallace; Scott Pardo; Joan Lee Parkes
Journal:  J Diabetes Sci Technol       Date:  2011-01-01

2.  Penny wise and pound foolish: will shortsighted cost reduction measures compromise patient access to promising self-monitoring of blood glucose technology?

Authors:  Christopher G Parkin
Journal:  J Diabetes Sci Technol       Date:  2013-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.